{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:22:52Z","timestamp":1781360572488,"version":"3.54.1"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Anti-mitochondrial antibody (AMA)-positive myositis is an atypical inflammatory myopathy characterized by chronic progression of muscle atrophy and cardiac involvement. Few detailed reports have shown the clinical course of the cardiac complications of AMA-positive myositis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 47-year-old man presented with shortness of breath on exertion. Cardiac dilatation was visible on chest X-ray, and echocardiography demonstrated diffuse hypokinesis with a reduced left ventricular (LV) ejection fraction of 30%. He had mild muscle weakness in the bilateral iliopsoas muscles, and his creatine kinase (CK) and anti-mitochondrial M2 antibody levels were elevated. A liver biopsy showed no findings of primary biliary cholangitis. Coronary angiography revealed normal coronary arteries. An endomyocardial biopsy showed interstitial fibrosis and marked degeneration of the mitochondria. Fluorodeoxyglucose (FDG)-positron emission tomography\/computed tomography showed circumferential abnormal accumulation in the LV myocardium, and he was diagnosed with cardiomyopathy associated with AMA-positive myositis. Optimal drug therapy for heart failure was started, and a cardiac resynchronization therapy-defibrillator was implanted. However, his cardiac function did not improve, and he was hospitalized due to ventricular tachycardia storm 5 years after the diagnosis. Ventricular tachycardia was terminated by radiofrequency catheter ablation on the LV-anterior papillary muscle. Steroid therapy was initiated and resulted in a decreased uptake of FDG and a normalized CK level at 3 months after his second discharge; however, LV systolic dysfunction remained 1 year later.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Anti-mitochondrial antibody-positive myositis can affect the myocardium and cause severe LV dysfunction and life-threatening ventricular arrhythmia over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Keywords<\/jats:title>\n                  <jats:p>Anti-mitochondrial antibody-positive myositis \u2022 Endomyocardial biopsy \u2022 Ventricular tachycardia \u2022 Left ventricular dysfunction \u2022 Case report \u2022 Magnetic resonance imaging \u2022 Near-infrared spectroscopy-intravascular ultrasound<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytab469","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T08:08:07Z","timestamp":1639987687000},"source":"Crossref","is-referenced-by-count":6,"title":["Life-threatening ventricular arrhythmia and left ventricular dysfunction associated with anti-mitochondrial antibody-positive myositis: a case report"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1554-1056","authenticated-orcid":false,"given":"Yuki","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences , 1-754 Asahimachidori, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0883-9279","authenticated-orcid":false,"given":"Daisuke","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences , 1-754 Asahimachidori, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kashimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences , 1-754 Asahimachidori, Niigata 951-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-6151","authenticated-orcid":false,"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"2022081608431745100_ytab469-B1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain"},{"key":"2022081608431745100_ytab469-B2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semarthrit.2017.06.004","article-title":"Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement","volume":"47","author":"Albayda","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2022081608431745100_ytab469-B3","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2169\/internalmedicine.56.8183","article-title":"Anti-mitochondrial M2 antibodies enhance the risk of supraventricular arrhythmias in patients with elevated hepatobiliary enzyme levels","volume":"56","author":"Konishi","year":"2017","journal-title":"Intern Med"},{"key":"2022081608431745100_ytab469-B4","first-page":"123","article-title":"Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic","volume":"38","author":"Koyama","year":"2017","journal-title":"Eur Heart J"},{"key":"2022081608431745100_ytab469-B5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-218469","article-title":"Antimitochondrial antibodies-positive myositis accompanied by cardiac involvement","author":"Yamanaka","year":"2017","journal-title":"BMJ Case Rep"},{"key":"2022081608431745100_ytab469-B6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/mus.23730","article-title":"Myositis with antimitochondrial antibodies diagnosed by rectus abdominis mucles biopsy","volume":"47","author":"Uenaka","year":"2013","journal-title":"Muscle Nerve"},{"key":"2022081608431745100_ytab469-B7","doi-asserted-by":"crossref","first-page":"1604.e9","DOI":"10.1016\/j.cjca.2019.07.002","article-title":"Variable cardiac responses to immunosuppressive therapy in anti-mitochondrial antibody-positive myositis","volume":"35","author":"Bujo","year":"2019","journal-title":"Can J Cardiol"},{"key":"2022081608431745100_ytab469-B8","doi-asserted-by":"crossref","first-page":"515.e3-6","DOI":"10.1016\/j.cjca.2011.12.010","article-title":"Successful steroid therapy for heart failure due to myocarditis associated with primary biliary cirrhosis","volume":"28","author":"Matsumoto","year":"2012","journal-title":"Can J Cardiol"},{"key":"2022081608431745100_ytab469-B9","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1093\/eurheartj\/ehy246","article-title":"Eosinophilic myocarditis associated with anti-mitochondrial M2 antibodies: a mechanism underlying the onset of myocarditis","volume":"39","author":"Saito","year":"2018","journal-title":"Eur Heart J"},{"key":"2022081608431745100_ytab469-B10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCEP.109.922310","article-title":"Electrocardiographic and electrophysiological characteristics in idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle: relevance for catheter ablation","volume":"3","author":"Yamada","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022081608431745100_ytab469-B11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2022081608431745100_ytab469-B12","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/12\/ytab469\/45435384\/ytab469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/12\/ytab469\/45435384\/ytab469.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T08:43:42Z","timestamp":1660639422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytab469\/6470235"}},"subtitle":[],"editor":[{"given":"Erik","family":"Holy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Josip Andelo","family":"Borovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"S\u00f8ren Z\u00f6ga","family":"Diederichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Domenico","family":"Filomena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Carlos Minguito","family":"Carazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Mariame","family":"Chakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytab469","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,12,1]]},"article-number":"ytab469"}}